Washington University ID-CRU conducts research in several areas such as: HIV treatment, HIV prevention, hepatitis, fungal infections, sexually transmitted diseases, the COVID-19 virus as well as various other general vaccine studies. No matter your health, age, or gender we may have a study for YOU. Here are a few of the studies for which we are currently enrolling.

HIV and PrEP Clinical Trials

A5332: Reprieve is one of our most popular studies for people with HIV. It focuses on heart disease prevention and maintaining cardiovascular health.

WU 311: PrEP@Home

A randomized clinical trial of a home care system for using Pre-Exposure Prophylaxis (PrEP) to help protect against HIV infections. Individuals entering into PrEP care at an initial in-person study visit will be randomized to the PrEP@Home system for home-based PrEP care follow-up visits or to standard of care for clinic-based follow-up visits. The primary aim of this study is to assess protective levels of PrEP medication for a home-based care compared to the standard of care.


The ID-CRU has many more ongoing studies. Also, transportation and monetary compensation are often provided.

These studies can be a great way to move science and healthcare forward while providing you with a chance to become engaged and informed. You will receive quality healthcare, individualized support and an opportunity to make a difference. Anyone can participate and we want you.

If interested please contact us to find out which studies are right for you, call us at 314-454-0058 or email at idcru@wustl.edu.